Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn clinical trials, adults taking Wegovy lost an average of around 15% of their body weight over 68 weeks — roughly 1 to 2 pounds a month in early treatment, accelerating as doses increase. That monthly figure varies considerably by individual, dose, diet and activity. Wegovy (semaglutide) is a prescription-only medicine in the UK; a prescriber assesses whether it's clinically suitable for you before any treatment begins. On the cost side, private UK treatment is priced per pen per month, and the headline figure doesn't always reflect the full picture of what you're paying for.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is some version of: "How much will I lose in the first month?" It's a fair thing to want to know. The honest answer is that the trial evidence (from the STEP 1 study, published in the New England Journal of Medicine) shows an average 15% reduction over 68 weeks at the 2.4mg maintenance dose. Spread across a treatment course, that works out at roughly one to two pounds a week once you're at a meaningful therapeutic dose. Month one, though, is different.
Month one is the 0.25mg starter period. That dose exists to let your system adjust, not to drive significant weight change. Most people don't see dramatic scale movement in the first four weeks, and that's expected. The dose climbs over subsequent months, typically in four-week steps guided by your prescriber, and weight loss over three months combined is more informative than any single month in isolation. Setting realistic expectations early saves a lot of unnecessary frustration.
Individual variation is real. Starting weight, metabolic rate, food choices, activity level and how your body responds to semaglutide all shape the result. If you want to understand how much weight loss semaglutide typically produces in a month, that page breaks down the evidence in more detail. The broader picture of Wegovy's weight-loss evidence covers this in more depth if you want the full data.
Private Wegovy in the UK is priced per pen, and the monthly cost depends on your current dose. Lower doses cost less; the maintenance doses cost more. Since Eli Lilly's list-price movement in late 2025, the market for tirzepatide shifted, and Wegovy pricing across UK providers now typically sits in a range most people didn't expect before they searched. Current Wegovy pricing in the UK covers the specifics without the headline-only framing.
What the headline number often leaves out is the part worth scrutinising. Some providers charge separately for the initial consultation, the prescription itself, delivery and clinical follow-up. Those add-ons are sometimes itemised after you've already decided to proceed. Others offer a low entry price at the starter dose, knowing most patients will titrate upward and the real monthly cost is higher by month three or four.
The higher 7.2mg dose, approved by the MHRA on 14 April 2026 as a dedicated single-dose pen, adds another pricing tier for patients who reach that stage. The 7.2mg Wegovy pen's UK price context is worth reading before you factor that into any long-term cost calculation.
At nume, we don't run promotions, discount codes or seasonal sales. That's a deliberate choice. We lose the headline price comparison on purpose, because what matters for a prescription medicine isn't who posts the lowest number, it's what that number actually covers.
Our single price includes the consultation, the prescription, the medicine, free next-working-day DPD delivery and priority aftercare seven days a week. No consultation fee billed separately. No delivery charge. No charge for the clinical re-review before every repeat. More about how the service is structured is on our about page if you want the full detail. Current treatment pricing is shown on the treatment page, not here, because we'd rather you see the complete picture in one place than a per-pen number stripped of its context.
Every prescription is reviewed by a named GPhC-registered Independent Prescriber. You can verify our pharmacy on the GPhC register (registration number 9012878) at pharmacyregulation.org. That's not a formality; it's the clearest signal that what you're buying comes from a regulated supply chain.
The MHRA has warned publicly about counterfeit weight-loss pens sold online and via social media. Fake pens have been found to contain insulin rather than the stated medicine, a potentially life-threatening substitution. Any listing offering Wegovy without a prior clinical assessment, or with prices far below the reported UK market range, is a serious red flag. The MHRA's Yellow Card scheme lets you report suspect sellers.
Price is worth comparing between legitimate, registered UK pharmacies. It is not, on its own, a safe basis for choosing one. For a medicine that requires careful titration, clinical monitoring and genuine supply-chain verification, the question isn't only what's the cheapest listing, it's what does the monthly cost include, and who is reviewing your treatment. If you're planning ahead, how much weight loss to expect in one month on Wegovy gives a realistic picture that's more useful than any single-month number or provider comparison.
If you'd like a prescriber to review your situation, start your free consultation here. No obligation. Reviewed the same day if you complete it before noon on a weekday.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.